Holmusk Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
101
- Latest Deal Type
-
Later Stage VC
- Investors
-
14
Holmusk General Information
Description
Developer of a real-world evidence platform designed to advance behavioral health analytics and improve clinical understanding. The company's platform incorporates a longitudinal de-identified database and more than one million patients, combines natural language processing, predictive disease models, and analytics dashboards, enabling researchers, healthcare providers, and payers to derive evidence-based insights for treatment development, care delivery optimization, and regulatory decision-making.
Contact Information
Website
www.holmusk.comCorporate Office
- 2nd Floor
- 54 Thompson Street
- New York, NY 10012
- United States
Corporate Office
- 2nd Floor
- 54 Thompson Street
- New York, NY 10012
- United States
Holmusk Timeline
Holmusk Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC | 26-Nov-2025 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 12-Oct-2023 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series B) | 06-Jan-2023 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series A1) | 07-Apr-2020 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Jul-2019 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 4. Accelerator/Incubator | 01-Feb-2019 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 25-Sep-2018 | Completed | Generating Revenue | |||
| 2. Seed Round | 02-Nov-2016 | $2.32M | $2.32M | Completed | Startup | |
| 1. Angel (individual) | Completed | Startup |
Holmusk Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A1 | ||||||||
| Series A | 319,364 | $17.45 | $17.45 | 1x | $17.45 | 6.87% | ||
| Seed | 149,500 | $15.51 | $15.51 | 1x | $15.51 | 3.22% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Holmusk Comparisons
Industry
Financing
Details
Holmusk Competitors (43)
One of Holmusk’s 43 competitors is Komodo Health, a Venture Capital-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Komodo Health | Venture Capital-Backed | New York, NY | ||||
| Innovaccer | Venture Capital-Backed | San Francisco, CA | ||||
| Lumeon | Formerly VC-backed | South Jordan, UT | ||||
| HealthVerity | Venture Capital-Backed | Philadelphia, PA | ||||
| Relatient | Private Equity-Backed | Atlanta, GA |
Holmusk Patents
Holmusk Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022231518-A1 | Systems and methods for retaining and analyzing health information | Inactive | 28-Apr-2021 |
Holmusk Signals
Holmusk Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Capikris Foundation | Venture Capital | Minority | ||
| dRx Capital Novartis | Venture Capital | Minority | ||
| Johnson & Johnson JJDC | Corporate Venture Capital | Minority | ||
| Northwell Holdings | Corporate Venture Capital | Minority | ||
| Novartis | Corporation | Minority |
Holmusk Acquisitions (2)
Holmusk’s most recent deal was a Merger/Acquisition with Otsuka Health Solutions. The deal was made on 27-Apr-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Otsuka Health Solutions | 27-Apr-2021 | Merger/Acquisition | Business/Productivity Software | ||
| MindLinc | 22-Mar-2016 | Merger/Acquisition | Medical Records Systems |
Holmusk FAQs
-
When was Holmusk founded?
Holmusk was founded in 2015.
-
Where is Holmusk headquartered?
Holmusk is headquartered in New York, NY.
-
What is the size of Holmusk?
Holmusk has 101 total employees.
-
What industry is Holmusk in?
Holmusk’s primary industry is Enterprise Systems (Healthcare).
-
Is Holmusk a private or public company?
Holmusk is a Private company.
-
What is Holmusk’s current revenue?
The current revenue for Holmusk is .
-
How much funding has Holmusk raised over time?
Holmusk has raised $114M.
-
Who are Holmusk’s investors?
Capikris Foundation, dRx Capital Novartis, Johnson & Johnson JJDC, Northwell Holdings, and Novartis are 5 of 14 investors who have invested in Holmusk.
-
Who are Holmusk’s competitors?
Komodo Health, Innovaccer, Lumeon, HealthVerity, and Relatient are some of the 43 competitors of Holmusk.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process